1y2g
From Proteopedia
(New page: 200px<br /><applet load="1y2g" size="450" color="white" frame="true" align="right" spinBox="true" caption="1y2g, resolution 1.90Å" /> '''Crystal STructure of...) |
|||
| Line 1: | Line 1: | ||
| - | [[Image:1y2g.gif|left|200px]]<br /><applet load="1y2g" size=" | + | [[Image:1y2g.gif|left|200px]]<br /><applet load="1y2g" size="350" color="white" frame="true" align="right" spinBox="true" |
caption="1y2g, resolution 1.90Å" /> | caption="1y2g, resolution 1.90Å" /> | ||
'''Crystal STructure of ZipA in complex with an inhibitor'''<br /> | '''Crystal STructure of ZipA in complex with an inhibitor'''<br /> | ||
==Overview== | ==Overview== | ||
| - | In this paper, we describe the first prospective application of the | + | In this paper, we describe the first prospective application of the shape-comparison program ROCS (Rapid Overlay of Chemical Structures) to find new scaffolds for small molecule inhibitors of the ZipA-FtsZ protein-protein interaction, a proposed antibacterial target. The shape comparisons are made relative to the crystallographically determined, bioactive conformation of a high-throughput screening (HTS) hit. The use of ROCS led to the identification of a set of novel, weakly binding inhibitors with scaffolds presenting synthetic opportunities to further optimize biological affinity and lacking development issues associated with the HTS lead. These ROCS-identified scaffolds would have been missed using other structural similarity approaches such as ISIS 2D fingerprints. X-ray crystallographic analysis of one of the new inhibitors bound to ZipA reveals that the shape comparison approach very accurately predicted the binding mode. These experimental results validate this use of ROCS for chemotype switching or "lead hopping" and suggest that it is of general interest for lead identification in drug discovery endeavors. |
==About this Structure== | ==About this Structure== | ||
| - | 1Y2G is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Escherichia_coli Escherichia coli] with CL3 as [http://en.wikipedia.org/wiki/ligand ligand]. Full crystallographic information is available from [http:// | + | 1Y2G is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Escherichia_coli Escherichia coli] with <scene name='pdbligand=CL3:'>CL3</scene> as [http://en.wikipedia.org/wiki/ligand ligand]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1Y2G OCA]. |
==Reference== | ==Reference== | ||
| Line 14: | Line 14: | ||
[[Category: Single protein]] | [[Category: Single protein]] | ||
[[Category: Mosyak, L.]] | [[Category: Mosyak, L.]] | ||
| - | [[Category: Rush, T | + | [[Category: Rush, T S.]] |
[[Category: CL3]] | [[Category: CL3]] | ||
[[Category: cell cycle]] | [[Category: cell cycle]] | ||
| - | ''Page seeded by [http:// | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 16:01:06 2008'' |
Revision as of 14:01, 21 February 2008
|
Crystal STructure of ZipA in complex with an inhibitor
Overview
In this paper, we describe the first prospective application of the shape-comparison program ROCS (Rapid Overlay of Chemical Structures) to find new scaffolds for small molecule inhibitors of the ZipA-FtsZ protein-protein interaction, a proposed antibacterial target. The shape comparisons are made relative to the crystallographically determined, bioactive conformation of a high-throughput screening (HTS) hit. The use of ROCS led to the identification of a set of novel, weakly binding inhibitors with scaffolds presenting synthetic opportunities to further optimize biological affinity and lacking development issues associated with the HTS lead. These ROCS-identified scaffolds would have been missed using other structural similarity approaches such as ISIS 2D fingerprints. X-ray crystallographic analysis of one of the new inhibitors bound to ZipA reveals that the shape comparison approach very accurately predicted the binding mode. These experimental results validate this use of ROCS for chemotype switching or "lead hopping" and suggest that it is of general interest for lead identification in drug discovery endeavors.
About this Structure
1Y2G is a Single protein structure of sequence from Escherichia coli with as ligand. Full crystallographic information is available from OCA.
Reference
A shape-based 3-D scaffold hopping method and its application to a bacterial protein-protein interaction., Rush TS 3rd, Grant JA, Mosyak L, Nicholls A, J Med Chem. 2005 Mar 10;48(5):1489-95. PMID:15743191
Page seeded by OCA on Thu Feb 21 16:01:06 2008
